What is the recommended management for acute liver failure?

Management of Acute Liver Failure

For acetaminophen-induced acute liver failure, immediately administer intravenous N-acetylcysteine; for all other causes, focus on intensive supportive care and early transfer to a liver transplant center for evaluation. 1

Immediate Etiology-Specific Treatment

N-Acetylcysteine Administration

• Acetaminophen toxicity: Give IV N-acetylcysteine immediately - this is the only strong recommendation with proven mortality benefit (relative risk 0.65) 1
• Non-acetaminophen ALF: NAC should only be used in clinical trials, though it may be considered for indeterminate causes that could be occult acetaminophen toxicity 1
• Post hoc analysis suggests possible benefit in early encephalopathy (stage 1-2), but overall mortality benefit in non-acetaminophen ALF was not demonstrated 1

Cause-Specific Interventions

The etiology determines both management and prognosis, requiring extensive investigation 2:

• Autoimmune hepatitis: Consider corticosteroids if autoantibodies positive (93% sensitivity) - patients receiving corticosteroids had better outcomes 1
• Viral hepatitis: Antivirals for hepatitis B; test for HEV in pregnant women 1
• Wilson's disease: Test and treat if identified 1
• HSV/VZV: Test and treat despite low-quality data, as therapies may be beneficial 1

Critical Care Management Framework

Hemodynamic and Metabolic Stabilization

The pathogenesis involves intense cytokine release causing multiorgan effects 3:

• Fluid balance optimization: Use continuous renal replacement therapy (CRRT) as needed 4, 3
• Vasopressor support: Required for cardiovascular collapse from systemic inflammation 3
• Metabolic monitoring: Active surveillance of glucose, electrolytes, and acid-base status 4, 5
• Nutritional support: Essential component of ICU management 4

Cerebral Edema Management

Do NOT use empiric treatments to reduce intracranial pressure - this is a conditional recommendation against routine ICP-lowering therapy 1. Five RCTs testing hypothermia, hypertonic saline, L-ornithine L-aspartate, mannitol, and hyperventilation showed no mortality benefit, and ICP monitoring itself carries morbidity 1.

However, cerebral edema remains a leading cause of death 2:

• Monitor for signs of elevated ICP clinically
• Consider "Quadruple H therapy" in specialized centers 6
• Early identification is critical even without routine invasive monitoring

Infection Prevention and Organ Support

Sepsis with multiorgan failure is the other leading cause of death 2:

• Active surveillance for infections - early identification alters ALF course 2
• Mechanical ventilation: Timely initiation when indicated 4
• Renal replacement therapy: CRRT for acute kidney injury 4, 3
• Coagulopathy management: Monitor but recognize this reflects synthetic failure 5, 6

Extracorporeal Liver Support Systems

Use artificial liver support systems ONLY within clinical trials 1. Despite theoretical benefits as a bridge to transplantation or spontaneous recovery:

• Seven RCTs (415 patients) showed no survival improvement overall 1
• More recent trials (past 20 years, 332 patients) showed marginally significant benefit 1
• Albumin dialysis: trend toward decreased mortality but not statistically significant 1
• Post hoc analysis of combined albumin and bioartificial systems: decreased mortality (RR 0.80) 1

Critical caveat: These systems have significant toxicities, are costly, and resource-intensive without robust evidence of benefit 1. Therapeutic plasma exchange may be useful, particularly in non-transplant centers 2.

Liver Transplantation Evaluation

Early evaluation for liver transplantation is essential, particularly for acetaminophen toxicity which evolves in 3-4 days 3. Subacute etiologies evolve over 2-4 weeks 3.

Prognostic Assessment

Use MELD score with fixed cut-off value of 30.5 as recommended predictive model 1. Other validated tools include:

• King's College Criteria 3, 7
• Acute Liver Failure Group prognostic index 3

Urgent Listing Indicators

Heightened need for urgent transplantation when:

• Vasopressor support required 3
• High-grade hepatic encephalopathy present 3
• Unfavorable (subacute) etiologies 3

Transfer Criteria

Transfer to liver transplant center ICU immediately - timely transfer and specialized supportive management are critical 5, 6. Indications for referral include:

• Any patient meeting ALF criteria (coagulopathy + encephalopathy without pre-existing liver disease)
• Particularly urgent for hyperacute presentations (acetaminophen, ischemia)
• Delay in acetaminophen cases is likely to lead to death 3

Common Pitfalls to Avoid

• Delaying NAC in acetaminophen toxicity while awaiting confirmatory levels
• Empirically treating elevated ICP without evidence of benefit
• Using extracorporeal support systems outside clinical trials
• Failing to transfer early to transplant centers, especially in rapidly evolving cases
• Missing treatable causes (HSV, autoimmune hepatitis, Wilson's disease) due to incomplete workup

The evidence consistently emphasizes that despite improvements, ALF carries high mortality 2, 5, 3. Multidisciplinary ICU care in specialized centers with transplant capability offers the best outcomes 4, 7.